ArticlePloS one2025
Alterations in lipid profiles in children with perinatally acquired HIV infection living in Ghana: A cross-sectional study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High dyslipidemia in people living with HIV in ghana: a cross-sectional analysis of prevalence and associated factors.AIDS research and therapy · 2025Article
- Long-term lipoprotein and lipid profiles and association with metabolic risk markers in youth with perinatally acquired HIV and matched controls: a 10-year comparative cohort study.Lipids in health and disease · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Children and adolescents who acquired HIV perinatally and are on lifelong antiretroviral therapy (ART) are at increased risk of lipid abnormalities, premature atherosclerosis, and early onset cardiovascular diseases (CVD). Majority of these children reside in sub-Saharan Africa, where monitoring of lipid profiles is not routine. In this study, we assessed the age dependent prevalence of dyslipidemia among children and adolescents who acquired HIV in Ghana and explored effects of age and sex. In this cross-sectional study, we examined lipid profiles of 397 children aged 6-18 years. Dyslipidemia was defined by elevated total cholesterol (TC) (≥200 mg/dL) or triglyceride (TG) levels (>150 mg/dL) or low-density lipoprotein cholesterol (LDL-C) (>130 mg/dL) or reduced high-density lipoprotein cholesterol (HDL-C) (<35 mg/dL). In subgroup analyses, dyslipidemia prevalence, by at least one criterion and for each criterion separately, was compared between age groups 6-12 (pre-teen) and 13-18 (teenage) years, as well as by sex, recognizing potential sample size limitations we state our findings and p-values. The overall prevalence of dyslipidemia was 42.32%, and by individual criterion was 9.07% using LDL-C, 11.84% using TC, 15.87% using TG, and 24.00% using HDL-C. Additionally, 5.04% (n = 20) of the participants showed abnormalities across three parameters. Teenagers had a higher overall prevalence of dyslipidemia (46.75% vs. 39.04%, p = 0.12). Criterion-based dyslipidemia prevalence varied across age groups, with TC-based (14.04% vs. 8.88%, p = 0.12) being higher in the pre-teen group, while elevated TG-based (20.12% vs. 12.72%, p = 0.05) and low levels of HDL-based (28.99% vs. 20.60%, p = 0.05) were more prevalent in the teenagers. The mean levels of TC (p = 0.04) and LDL-C (p = 0.03) were significantly higher in the pre-teen age groups. Females had nearly twice as high as that of males with prevalence of abnormal LDL-C levels (11.39% vs. 6.67%, p = 0.13). We observed varying trends in the prevalence of dyslipidemia and lipid profile levels across age and sex groups, likely influenced by developmental and hormonal changes, although most differences were not statistically significant. This study showed a high prevalence of dyslipidemia among children who acquired HIV perinatally and are on ART, with possible age-related and sex variations in lipid profiles likely influenced by developmental and hormonal changes. These findings emphasize the importance of implementing routine monitoring for lipid disorders within this population and further confirmatory investigation of effects of age and sex as these children grow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.